BioCentury
ARTICLE | Clinical News

IV OCR-002: Ph IIb STOP-HE data

February 3, 2017 8:34 PM UTC

Top-line data from the double-blind, international Phase IIb STOP-HE trial in 231 hospitalized acute hepatic encephalopathy patients with liver cirrhosis and elevated serum ammonia levels showed that ...

BCIQ Company Profiles

Ocera Therapeutics Inc.